For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $77.88 in the prior trading day, Revolution Medicines Inc (NASDAQ: RVMD) closed at $78.51, up 0.81%. In other words, the price has increased by $0.81 from its previous closing price. On the day, 2.02 million shares were traded. RVMD stock price reached its highest trading level at $79.6 during the session, while it also had its lowest trading level at $77.54.
Ratios:
Our goal is to gain a better understanding of RVMD by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.05 and its Current Ratio is at 8.05. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In the most recent recommendation for this company, Wolfe Research on November 18, 2025, initiated with a Outperform rating and assigned the stock a target price of $75. On November 03, 2025, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $77. On October 21, 2025, Mizuho started tracking the stock assigning a Outperform rating and target price of $90.Mizuho initiated its Outperform rating on October 21, 2025, with a $90 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 25 ’25 when Anders Jack sold 5,418 shares for $74.00 per share. The transaction valued at 400,932 led to the insider holds 110,994 shares of the business.
GOLDSMITH MARK A sold 60,000 shares of RVMD for $4,504,962 on Nov 25 ’25. The insider now owns 247,863 shares after completing the transaction at $75.08 per share. On Nov 25 ’25, another insider, GOLDSMITH MARK A, who serves as the insider of the company, sold 6,000 shares for $75.00 each. As a result, the insider received 450,000 and left with 67,424 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RVMD now has a Market Capitalization of 15177538560 and an Enterprise Value of 13660999680.
Stock Price History:
The Beta on a monthly basis for RVMD is 0.99, which has changed by 0.744279 over the last 52 weeks, in comparison to a change of 0.14045572 over the same period for the S&P500. Over the past 52 weeks, RVMD has reached a high of $81.49, while it has fallen to a 52-week low of $29.17. The 50-Day Moving Average of the stock is 25.78%, while the 200-Day Moving Average is calculated to be 75.62%.
Shares Statistics:
The stock has traded on average 2.30M shares per day over the past 3-months and 2012600 shares per day over the last 10 days, according to various share statistics. A total of 189.71M shares are outstanding, with a floating share count of 165.29M. Insiders hold about 14.50% of the company’s shares, while institutions hold 88.60% stake in the company. Shares short for RVMD as of 1764288000 were 16792419 with a Short Ratio of 7.29, compared to 1761868800 on 18022242. Therefore, it implies a Short% of Shares Outstanding of 16792419 and a Short% of Float of 9.22.
Earnings Estimates
The dynamic stock of Revolution Medicines Inc (RVMD) is currently attracting attention from 15.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is -$1.65, with high estimates of -$1.44 and low estimates of -$1.8.
Analysts are recommending an EPS of between -$4.92 and -$5.76 for the fiscal current year, implying an average EPS of -$5.54. EPS for the following year is -$6.29, with 17.0 analysts recommending between -$4.49 and -$7.63.
